Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Vermeer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|April 5, 2024
Cutaneous T-cell lymphoma care across Europe: insights from the HORIZON programmeGabriele Roccuzzo, Joana Calvão, Gabor Dobos, et al.
Hematological Oncology|August 31, 2023
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panelPietro Quaglino, Nicola Pimpinelli, Pier Luigi Zinzani, et al.
The Lancet. Oncology|June 30, 2019
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trialMartine Bagot, Pierluigi Porcu, Anne Marie-Cardine, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Blood Cancer Journal|May 16, 2020
Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndromeAndreas Willerslev-Olsen, Terkild B Buus, Claudia Nastasi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2024
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour groupKhaled Elsayad, Emmanuella Guenova, Chalid Assaf, et al.
The British Journal of Dermatology|May 27, 2025
ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatmentEmmilia Hodak, Iris Amitay-Laish, Martine Bagot, et al.
The British Journal of Dermatology|May 27, 2025
ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and stagingEmmilia Hodak, Iris Amitay-Laish, Martine Bagot, et al.
Blood|November 10, 2021
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCElise A Olsen, Sean Whittaker, Rein Willemze, et al.
The Lancet. Oncology|August 14, 2018
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trialYoun H Kim, Martine Bagot, Lauren Pinter-Brown, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|April 5, 2024
Cutaneous T-cell lymphoma care across Europe: insights from the HORIZON programmeGabriele Roccuzzo, Joana Calvão, Gabor Dobos, et al.
Hematological Oncology|August 31, 2023
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panelPietro Quaglino, Nicola Pimpinelli, Pier Luigi Zinzani, et al.
The Lancet. Oncology|June 30, 2019
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trialMartine Bagot, Pierluigi Porcu, Anne Marie-Cardine, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Blood Cancer Journal|May 16, 2020
Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndromeAndreas Willerslev-Olsen, Terkild B Buus, Claudia Nastasi, et al.
European Journal of Cancer (Oxford, England : 1990)|October 17, 2024
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour groupKhaled Elsayad, Emmanuella Guenova, Chalid Assaf, et al.
The British Journal of Dermatology|May 27, 2025
ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part two: treatmentEmmilia Hodak, Iris Amitay-Laish, Martine Bagot, et al.
The British Journal of Dermatology|May 27, 2025
ISCL/EORTC-CLTG/USCLC recommendations for the diagnosis, staging and treatment of early-stage paediatric mycosis fungoides: a modified Delphi consensus. Part one: diagnosis and stagingEmmilia Hodak, Iris Amitay-Laish, Martine Bagot, et al.
Blood|November 10, 2021
Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCElise A Olsen, Sean Whittaker, Rein Willemze, et al.
The Lancet. Oncology|August 14, 2018
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trialYoun H Kim, Martine Bagot, Lauren Pinter-Brown, et al.
Pageof 3